These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19342361)

  • 21. Standard and high dose ergocalciferol regimens for treatment of hypovitaminosis D in epileptic children and adolescents.
    Vichutavate S; Suwanpakdee P; Likasitthananon N; Numbenjapon N; Nabangchang C; Phatarakijnirund V
    J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1369-1376. PubMed ID: 36190481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Effect of Ergocalciferol on Bone Metabolism Indexes and Parathyroid Hormone in Hemodialysis Patients.
    Bashardoust B; Zakeri A; Fouladi N; Izadi Z; Hosseini F
    Iran J Kidney Dis; 2018 Nov; 12(6):359-363. PubMed ID: 30595565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
    Melhem SJ; Aiedeh KM; Hadidi KA
    Ann Saudi Med; 2015; 35(1):13-8. PubMed ID: 26142932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.
    Dreyer G; Tucker AT; Harwood SM; Pearse RM; Raftery MJ; Yaqoob MM
    PLoS One; 2014; 9(7):e99461. PubMed ID: 25006678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women.
    Mueangpaisarn P; Chaiamnuay S
    Aging Clin Exp Res; 2020 Jan; 32(1):41-48. PubMed ID: 30784012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report: Three patients with substantial serum levels of 3-epi-25(OH)D including one with 3-epi-25(OH)D2 while on high-dose ergocalciferol.
    Wiebe D; Binkley N
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1117-21. PubMed ID: 24476080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D Supplementation Improves Quality of Life and Physical Performance in Osteoarthritis Patients.
    Manoy P; Yuktanandana P; Tanavalee A; Anomasiri W; Ngarmukos S; Tanpowpong T; Honsawek S
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.
    Burnett-Bowie SA; Leder BZ; Henao MP; Baldwin CM; Hayden DL; Finkelstein JS
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):624-31. PubMed ID: 22300739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difficulty Achieving Vitamin D Sufficiency With High-Dose Oral Repletion Therapy in Infants With Cholestasis.
    Jensen M; Abu-El-Haija M; Bishop W; Rahhal RM
    J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):187-9. PubMed ID: 25651487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of high dose vitamin D3 therapy on serum vitamin D3 levels in vitamin D insufficient adults with cystic fibrosis.
    Regalado Lam Chew Tun R; Porhownik N; Taback S; Oleschuk C
    Clin Nutr ESPEN; 2018 Feb; 23():84-88. PubMed ID: 29460819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Retrospective Evaluation of Response to Vitamin D Supplementation in Obese Versus Nonobese Patients.
    Bryant GA; Koenigsfeld CF; Lehman NP; Smith HL; Logemann CD; Phillips KT
    J Pharm Pract; 2015 Dec; 28(6):543-7. PubMed ID: 25124377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
    Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
    Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
    Khazai NB; Judd SE; Jeng L; Wolfenden LL; Stecenko A; Ziegler TR; Tangpricha V
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2037-43. PubMed ID: 19336509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.
    Leaf DE; Korets R; Taylor EN; Tang J; Asplin JR; Goldfarb DS; Gupta M; Curhan GC
    Clin J Am Soc Nephrol; 2012 May; 7(5):829-34. PubMed ID: 22422535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P; Nakwan S; Peerapornratana S; Tiranathanagul K; Katavetin P; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    BMC Nephrol; 2017 Jan; 18(1):19. PubMed ID: 28088187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.
    Binkley N; Gemar D; Engelke J; Gangnon R; Ramamurthy R; Krueger D; Drezner MK
    J Clin Endocrinol Metab; 2011 Apr; 96(4):981-8. PubMed ID: 21289249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of Optimal Vitamin D Dosage in Children with Cholestasis.
    Chongthavornvasana S; Lertudomphonwanit C; Mahachoklertwattana P; Korwutthikulrangsri M
    BMC Pediatr; 2023 Jun; 23(1):313. PubMed ID: 37344793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5.
    Rianthavorn P; Boonyapapong P
    Pediatr Nephrol; 2013 Aug; 28(8):1261-6. PubMed ID: 23420502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.